Form 4: Roivant CFO Sells Shares for Tax Obligations

Roivant Sciences CFO Richard Pulik disposed of 2,129 common shares to cover tax withholding obligations related to vested restricted stock units.

Summary

• Richard Pulik, Chief Financial Officer (CFO) of Roivant Sciences Ltd. (ROIV), reported a transaction involving common shares.
• On September 20, 2025, Mr. Pulik disposed of 2,129 common shares.
• The disposition was a 'net settlement' by the Issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
• The shares were disposed of at a price of $15.04 per share.
• Following this transaction, Mr. Pulik beneficially owns 391,849 common shares directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary insider transaction for tax purposes, which is neutral in sentiment and does not indicate positive or negative company performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction for tax purposes and does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and not a discretionary sale based on market outlook.

Key Dates

Keywords

Roivant Sciences, ROIV, Richard Pulik, CFO, Insider Transaction, Form 4, SEC Filing, Stock Sale, Tax Withholding, RSU Vesting